Zhao Dong, Huang Yi-Ming, Liang Zi-Ming, Zhang Kang-Jun, Fang Tai-Shi, Yan Xu, Jin Xin, Zhang Yi, Tang Jian-Xin, Xie Lin-Jie, Zeng Xin-Chen
Department of Liver Surgery and Organ Transplantation Center, The Third People's Hospital of Shenzhen, The Second Affiliated Hospital of Southern University of Science and Technology, National Clinical Research Center for Infectious Disease, Shenzhen 518000, Guangdong Province, China.
World J Gastrointest Surg. 2022 Oct 27;14(10):1131-1140. doi: 10.4240/wjgs.v14.i10.1131.
Thrombectomy and anatomical anastomosis (TAA) has long been considered the optimal approach to portal vein thrombosis (PVT) in liver transplantation (LT). However, TAA and the current approach for non-physiological portal reconstructions are associated with a higher rate of complications and mortality in some cases.
To describe a new choice for reconstructing the portal vein through a posterior pancreatic tunnel (RPVPPT) to address cases of unresectable PVT.
Between August 2019 and August 2021, 245 adult LTs were performed. Forty-five (18.4%) patients were confirmed to have PVT before surgery, among which seven underwent PV reconstruction the RPVPPT approach. We retrospectively analyzed the surgical procedure and postoperative complications of these seven recipients that underwent PV reconstruction due to PVT.
During the procedure, PVT was found in all the seven cases with significant adhesion to the vascular wall and could not be dissected. The portal vein proximal to the superior mesenteric vein was damaged in one case when attempting thrombolectomy, resulting in massive bleeding. LT was successfully performed in all patients with a mean duration of 585 min (range 491-756 min) and mean intraoperative blood loss of 800 mL (range 500-3000 mL). Postoperative complications consisted of chylous leakage ( = 3), insufficient portal venous flow to the graft ( = 1), intra-abdominal hemorrhage ( = 1), pulmonary infection ( = 1), and perioperative death ( = 1). The remaining six patients survived at 12-17 mo follow-up.
The RPVPPT technique might be a safe and effective surgical procedure during LT for complex PVT. However, follow-up studies with large samples are still warranted due to the relatively small number of cases.
长期以来,血栓切除术和解剖吻合术(TAA)一直被认为是肝移植(LT)中门静脉血栓形成(PVT)的最佳治疗方法。然而,TAA以及目前非生理性门静脉重建的方法在某些情况下会导致更高的并发症发生率和死亡率。
描述一种通过后胰隧道重建门静脉(RPVPPT)的新方法,以解决不可切除的PVT病例。
2019年8月至2021年8月期间,共进行了245例成人LT手术。45例(18.4%)患者术前确诊为PVT,其中7例采用RPVPPT方法进行门静脉重建。我们回顾性分析了这7例因PVT接受门静脉重建的受者的手术过程和术后并发症。
术中发现所有7例患者均存在PVT,与血管壁粘连严重,无法分离。1例在尝试血栓切除术时,肠系膜上静脉近端门静脉受损,导致大出血。所有患者LT手术均成功,平均手术时间为585分钟(范围491 - 756分钟),平均术中出血量为800毫升(范围500 - 3000毫升)。术后并发症包括乳糜漏(= 3)、移植门静脉血流不足(= 1)、腹腔内出血(= 1)、肺部感染(= 1)和围手术期死亡(= 1)。其余6例患者在12 - 17个月的随访中存活。
RPVPPT技术可能是LT治疗复杂PVT时一种安全有效的手术方法。然而,由于病例数量相对较少,仍需要大样本的随访研究。